Shire to acquire Movetis

DUBLIN Shareholders of Belgian drug maker Movetis have put up nearly all of their shares for sale as British drug maker Shire moves to acquire the company, Shire said Thursday.

 

Shire said 99.18% of Movetis’ shares had been tendered as of Monday.

 

 

Shire announced last month that it would buy Movetis for $567 million. The Turnhout, Belgium-based company makes gastroenterology drugs.